Work

Trametinib for the treatment of IGHV4-34, MAP2K1-mutant variant hairy cell leukemia

Year: 2017

Type: article

Abstract: Variant hairy cell leukemia (vHCL) is an uncommon disorder accounting for 10% of all HCL cases [1]. The difference in therapeutic response to chemotherapy between patients with classic HCL (cHCL) a...

Source: Leukemia & lymphoma/Leukemia and lymphoma

DOI: 10.1080/10428194.2017.1365853

Authors: Leslie A. Andritsos, Nicole R. Grieselhuber, Mirela Anghelina, Kerry A. Rogers, Sameek Roychowdhury, Julie W. Reeser, Cynthia D. Timmers, Aharon G. Freud, James S. Blachly, David M. Lucas, Gerard Lozanski, Jeffrey A. Jones, Katie Williams, Christopher Oakes, Dan Jones, Michael R. Grever

Institution: The Ohio State University

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Cancer Institute

Award: Cancer Center Support Grant

OpenAlex ID: W2754317274

FWCI: 1.472

Cites: 17

Cited by: 38

Related to: 10